Advertisement
Screener

Warby Parker Inc. (WRBY) EBITDA

Warby Parker Inc. (WRBY) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $17.24M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA $15.44M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $6.25M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $16.10M*; Operating income $3.57M; Depreciation and amortization $12.53M*.

Complete source-backed ebitda history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$17.24M(m)(m)(m)7.32%$22.86M*$29.62M*$99.05M(m)$133.29M$607.00K
2026-03-31Reported$15.44M(m)(m)(m)6.37%$16.14M$24.51M$111.41M(m)$129.37M$821.00K
2025-12-31Reported$6.25M(m)(m)(m)2.95%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$16.10M*$3.57M$12.53M*$221.68M7.26%*$19.49M*$17.97M*$101.73M(m)$116.38M-$125.00K
2025-06-30Reported$7.96M(m)(m)(m)3.71%$16.29M*$40.20M*$100.87M(m)$118.13M-$789.00K
2025-03-31Reported$14.63M(m)(m)(m)6.54%$16.15M$29.36M$97.80M(m)$123.51M$1.45M
2024-12-31Reported$2.92M(m)(m)(m)1.53%(m)(m)(m)(m)(m)(m)
2024-09-30Reported$5.22M*-$6.61M$11.83M*$192.45M2.71%*$14.22M*$27.28M*$87.58M(m)$111.48M$301.00K
2024-06-30Reported$2.17M*-$8.96M$11.12M*$188.22M1.15%*$17.65M*$31.62M*$82.84M(m)$114.34M$373.00K
2024-03-31Reported$5.46M(m)(m)(m)2.73%$14.44M$19.93M$86.54M(m)$118.59M$108.00K
2023-12-31Reported-$11.2M(m)(m)(m)-6.92%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$10.01M*-$19.77M$9.76M*$169.85M-5.89%*$15.49M*$19.93M*$77.12M(m)$112.50M$301.00K
2023-06-30Reported-$8.95M*-$18.23M$9.28M*$166.09M-5.39%*$12.22M*$18.75M*$75.46M(m)$108.86M-$24.00K
2023-03-31Reported-$3.29M(m)(m)(m)-1.91%$12.38M$8.64M$77.18M(m)$107.22M$261.00K
2022-12-31Reported-$12.79M(m)(m)(m)-8.73%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$15.33M*-$23.67M$8.34M*$148.78M-10.30%*$14.10M*$1.16M*$64.36M(m)$108.09M-$12.00K
2022-06-30Reported-$24.2M(m)(m)(m)-16.17%$15.81M*-$4.33M*$63.28M(m)$118.43M$47.00K
2022-03-31Reported-$26.83M(m)(m)(m)-17.51%$16.06M-$10.30M$63.57M(m)$123.39M$539.00K
2021-12-31Reported-$39.53M(m)(m)(m)-29.75%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$86.62M*-$91.98M$5.36M*$137.37M-63.05%*$12.80M*$4.96M*$57.71M(m)$171.64M-$1.05M
2021-06-30Reported-$3.69M(m)(m)(m)-2.80%$12.53M*-$1.82M*$53.51M(m)$86.86M$1.06M
2021-03-31Reported$7.73M(m)(m)(m)5.56%$8.69M-$3.28M$55.19M(m)$80.76M$144.00K
2020-12-31Reported-$648,000.00(m)(m)(m)-0.57%(m)(m)(m)(m)(m)(m)
2020-09-30Reported(m)-$41.34M(m)$104.09M(m)(m)(m)$40.11M(m)$105.31M$196.00K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$44.94M(m)(m)(m)5.15%$67.05M$110.78M$401.33M(m)$475.92M$1.40M
2024-12-31Reported$15.75M(m)(m)(m)2.04%$64.03M$98.74M$344.48M(m)$456.95M$875.00K
2023-12-31Reported-$33.44M(m)(m)(m)-4.99%$53.67M$60.99M$304.54M(m)$437.22M$433.00K
2022-12-31Reported-$79.34M(m)(m)(m)-13.26%$60.18M$10.37M$257.05M(m)$452.26M$497.00K
2021-12-31Reported-$122.11M(m)(m)(m)-22.58%$48.51M-$31.99M$223.05M(m)$461.41M$263.00K
2020-12-31Reported-$37.87M(m)(m)(m)-9.62%$20.07M$32.76M$161.78M(m)$287.57M$190.00K
2019-12-31Reported$12.85M(m)(m)(m)3.47%$32.63M$21.39M$147.35M(m)$224.77M$276.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
National Vision Holdings, Inc. (EYE)United States$1.297B
STAAR SURGICAL CO (STAA)United States$0.957B362.70
RxSight, Inc. (RXST)United States$0.197B
Innovative Eyewear Inc (LUCY)United States$0.008B
Bausch & Lomb Corp (BLCO)Canada$6.008B-34.58
COOPER COMPANIES, INC. (COO)United States$10.533B24.09